Walsall Healthcare NHS Trust 

Commercial Capabilities

KEY INFORMATION

Innovative Research task force including: 

• Hybrid roles in Maternity, Palliative care & End of life Care

• Introduction of LAB post to support research 

• Nurse Associates/Clinical Academic links and AHP supporting research leading to an increase in AHP/Nurse led Research

• Diversity of Research team in supporting research - Ownership on leading research responsibilities within the team

• Student nurse short term placements within FORCE (Education/Research collaboration) and also support student nurses, A-Level students in spending time with Education/Research on short placements.

• There are Staff development/CPD opportunities for the whole team

• Data officer in post to support data heavy studies

• R&D was nominated for Best Non-Clinical Team of the year 2021 and 2 leaders within the team nominated for leadership awards 2021

SPECIALIST EQUIPMENT

• Increase in the number of sponsors choosing to open studies at Walsall 

• Trust works in collaboration with The Royal Wolverhampton Hospital NHS Trust

• Collaborative working between the Trust and Compton Care

• Research participants encouraged to share their stories of experiences being involved in research

• NIHR I&I funding success -Hexitime project

• Reduced set-up times for opening studies

• Aim for 8 weeks set up time

• Recruitment Strategy plans are established very early on

CHIEF INVESTIGATOR/PRINCIPAL  INVESTIGATOR EXPERTISE

• Fantastic pool of PIs to support research including nurses, AHPs and Medics

AREAS KEEN TO GROW

• Aim to grow and develop research within the Community-strengthened links  

• Want to ensure research is reaching under-represented groups within Walsall, improving Research access and opportunities  

• Aim to increase own account research within the Team/Trust

• Want to increase research opportunities  within Palliative & End of Life 

RECRUITMENT ACHIEVEMENTS 

• Walsall Healthcare NHS Trust is the first in Europe to offer a potential breakthrough new clinical trial for youngsters who suffer from severe hand eczema. The DELTA Teen study is available for young patients aged 12-17 who are eligible to try a new medication

• First site in Europe to open a dermatology study for Adolescence’s

Research 

Team